1. Home
  2. NXPLW vs TBBK Comparison

NXPLW vs TBBK Comparison

Compare NXPLW & TBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPLW
  • TBBK
  • Stock Information
  • Founded
  • NXPLW N/A
  • TBBK 1999
  • Country
  • NXPLW United States
  • TBBK United States
  • Employees
  • NXPLW 166
  • TBBK N/A
  • Industry
  • NXPLW Telecommunications Equipment
  • TBBK Major Banks
  • Sector
  • NXPLW Telecommunications
  • TBBK Finance
  • Exchange
  • NXPLW Nasdaq
  • TBBK Nasdaq
  • Market Cap
  • NXPLW N/A
  • TBBK N/A
  • IPO Year
  • NXPLW N/A
  • TBBK 2004
  • Fundamental
  • Price
  • NXPLW N/A
  • TBBK $45.60
  • Analyst Decision
  • NXPLW
  • TBBK Buy
  • Analyst Count
  • NXPLW 0
  • TBBK 3
  • Target Price
  • NXPLW N/A
  • TBBK $67.67
  • AVG Volume (30 Days)
  • NXPLW 6.4K
  • TBBK 867.6K
  • Earning Date
  • NXPLW 03-31-2025
  • TBBK 04-24-2025
  • Dividend Yield
  • NXPLW N/A
  • TBBK N/A
  • EPS Growth
  • NXPLW N/A
  • TBBK 22.92
  • EPS
  • NXPLW N/A
  • TBBK 4.29
  • Revenue
  • NXPLW $66,482,000.00
  • TBBK $495,381,000.00
  • Revenue This Year
  • NXPLW N/A
  • TBBK N/A
  • Revenue Next Year
  • NXPLW N/A
  • TBBK $8.21
  • P/E Ratio
  • NXPLW N/A
  • TBBK $10.63
  • Revenue Growth
  • NXPLW 179.89
  • TBBK 10.62
  • 52 Week Low
  • NXPLW $0.25
  • TBBK $29.92
  • 52 Week High
  • NXPLW $0.26
  • TBBK $65.84
  • Technical
  • Relative Strength Index (RSI)
  • NXPLW N/A
  • TBBK 41.99
  • Support Level
  • NXPLW N/A
  • TBBK $44.89
  • Resistance Level
  • NXPLW N/A
  • TBBK $47.07
  • Average True Range (ATR)
  • NXPLW 0.00
  • TBBK 3.12
  • MACD
  • NXPLW 0.00
  • TBBK -0.08
  • Stochastic Oscillator
  • NXPLW 0.00
  • TBBK 35.52

About NXPLW NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

Share on Social Networks: